Reed's Inc. Announces First Quarter 2013 Results LOS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Reed's Inc. Announces First Quarter 2013 Results

LOS ANGELES, CA--(Marketwired - May 14, 2013) - Reed's, Inc. ( NYSE MKT : REED ), maker of the top-selling sodas in natural food stores nationwide, today announced the financial results for its first quarter ended March 31, 2013.

Financial Highlights for the Quarter:

  • Revenues increased 24% in the first quarter to $8.1 million in 2013, compared to 2012.
  • Gross profit increased 28% to $2.5 million in 2013.
  • Earnings before non-cash items and finance costs (modified EBITDA) decreased to $25,000 during the 2013 quarter. (See EBITDA table at end of this release for further non-GAAP information).
  • Net loss for the 2012 first quarter was $403,000 compared to a loss of $124,000 a year earlier.
  • Working capital at March 31, 2013 was $2.1 million, as compared to $2.3 million at December 31, 2012.

Operational Highlights:

  • Added four new flavors of our Reed's Culture Club Kombucha doubling them to eight
  • Commenced production for a significant new private label customer

"We are very pleased with our top line and margin growth for the quarter," stated Chris Reed, Founder and CEO at Reed's Inc. "Our branded sales continue to expand at a healthy rate. We doubled the number of flavors in our Reed's Culture Club Kombucha line to eight. The new flavors are some of our finest work with flavors like Coconut Water Lime Kombucha and Cabernet Grape Kombucha. In addition, we secured a large private label customer in the foodservice industry that has significant potential. This first quarter profits were reduced considerably by the west coast plant being turned off for production of our core brands while we geared up our Kombucha production. We have figured out how to run our Kombucha more efficiently and expect to see the first quarter inefficiencies fade as the year progresses. We expect our growth to continue."

James Linesch, Chief Financial Officer, stated, "Our delivery freight increased to excessive levels in the first quarter. Other than the normal freight rate increases, there are two primary factors contributing to the increase. First, due to our west coast plant being consumed with Kombucha production, we were producing most of our branded products on the east coast and had to use expensive temperature controlled shipping to protect the shipments from freezing in the winter. Second, we expanded our Pacific Northwest business at a faster rate than other regions, which is our highest freight cost region. We are currently upgrading our plant and our procedures to accommodate a significant increase in volume. We expect to start producing our core brands again in the west coast plant soon which will drive down freight costs and our unabsorbed plant costs will also reduce with the increased utilization improving margins."

The Company will conduct a conference call @ 4:15PM EDT on May 14th to discuss its 2013 first quarter results and outlook for the future. To participate in the call, please dial the following number 5 to 10 minutes prior to the scheduled call time (866) 240-5139. International callers should dial (713) 481-0091.

A replay will be available within a few days after the meeting in the investor relations section of the Company's website at: http://www.reedsinc.com/investors/ .

About Reed's, Inc.

Reed's, Inc. makes the top-selling natural sodas in the natural foods industry sold in over 13,000 natural food markets and supermarkets nationwide. Its six award-winning non-alcoholic Ginger Brews are unique in the beverage industry, being brewed, not manufactured and using fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks. The Company owns the top-selling root beer line in natural foods, the Virgil's Root Beer product line, and a top-selling cola line in natural foods, the China Cola product line. In 2012, the Company launched Reed's Culture Club Kombucha line of organic live beverages. Other product lines include: Reed's Ginger Candies and Reed's Ginger Ice Creams. In 2009, Reed's started producing private label natural beverages for select national chains. Reed's products are sold through specialty gourmet and natural food stores, mainstream supermarket chains, retail stores and restaurants nationwide, and in Canada, as well as through private label relationships with major supermarket chains.

For more information about Reed's, please visit the Company's website at: http://www.reedsinc.com or call 800-99-REEDS.

Follow Reed's on Twitter at http://twitter.com/reedsgingerbrew

Reed's Facebook Fan Page at https://www.facebook.com/ReedsGingerBrew

SAFE HARBOR STATEMENT

Some portions of this press release, particularly those describing Reed's goals and strategies, contain "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe future plans, objectives or goals are also forward-looking statements. While Reed's is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These risks and uncertainties include difficulty in marketing its products and services, maintaining and protecting brand recognition, the need for significant capital, dependence on third party distributors, dependence on third party brewers, increasing costs of fuel and freight, protection of intellectual property, competition and other factors, any of which could have an adverse effect on the business plans of Reed's, its reputation in the industry or its expected financial return from operations and results of operations. In light of significant risks and uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by Reed's that they will achieve such forward-looking statements. For further details and a discussion of these and other risks and uncertainties, please see our most recent reports on Form 10-K and Form 10-Q, as filed with the Securities and Exchange Commission, as they may be amended from time to time. Reed's undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

   
REED'S, INC.  
CONDENSED STATEMENTS OF OPERATIONS  
For the Three Months Ended March 31, 2013 and 2012  
(Unaudited)  
   
    Three months ended March 31,  
    2013     2012  
                 
  Sales   $ 8,126,000     $ 6,539,000  
                   
  Cost of tangible goods sold     4,905,000       4,185,000  
  Cost of goods sold - idle capacity     686,000       369,000  
                   
      Gross profit     2,535,000       1,985,000  
                   
  Operating expenses:                
                   
  Delivery and handling expense     906,000       479,000  
  Selling and marketing expense     880,000       722,000  
  General and administrative expense     988,000       740,000  
    Total operating expenses     2,774,000       1,941,000  
                   
      (Loss) income from operations     (239,000 )     44,000  
                   
  Interest expense     (164,000 )     (168,000 )
                   
  Net loss     (403,000 )     (124,000 )
                   
  Preferred stock dividend     -       (9,000 )
                   
  Net loss attributable to common stockholders   $ (403,000 )   $ (133,000 )
                 
Loss per share available to common stockholders - basic and diluted   $ (0.03 )   $ (0.01 )
Weighted average number of shares outstanding - basic and diluted     12,320,516       10,921,076  
                 
                 
                 
MODIFIED EBITDA SCHEDULE  
    Three Months Ended March 31,  
    2013     2012  
Net loss   $ (403,000 )   $ (124,000 )
                 
Modified EBITDA adjustments:                
                 
Depreciation and amortization     145,000       183,000  
Interest expense     164,000       168,000  
Stock option compensation     119,000       26,000  
Other stock compensation for services     -       15,000  
  Total EBITDA adjustments     428,000       392,000  
                 
Modified EBITDA income from operations   $ 25,000     $ 268,000  
                 

The Company defines modified EBITDA (a non-GAAP measurement) as net loss before interest, taxes, depreciation and amortization, and non-cash expense paid with company securities. Other companies may calculate modified EBITDA differently. Management believes that the presentation of modified EBITDA provides a measure of performance that approximates cash flow before interest expense, and is meaningful to investors.

   
REED'S, INC.  
CONDENSED BALANCE SHEETS  
   
    March 31, 2013     December 31, 2012  
ASSETS   (unaudited)        
Current assets:                
  Cash   $ 726,000     $ 1,163,000  
  Inventory     6,301,000       5,794,000  
  Trade accounts receivable, net of allowance for doubtful accounts and returns and discounts of $300,000 and $399,000, respectively     2,228,000       1,961,000  
  Prepaid inventory     190,000       201,000  
  Prepaid and other current assets     251,000       212,000  
    Total Current Assets     9,696,000       9,331,000  
                 
Property and equipment, net of accumulated depreciation of $2,471,000 and $2,351,000, respectively     3,400,000       3,422,000  
Brand names     1,029,000       1,029,000  
Deferred financing fees, net of amortization of $38,000 and $26,000, respectively     42,000       54,000  
    Total assets   $ 14,167,000     $ 13,836,000  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current Liabilities:                
  Accounts payable   $ 3,396,000     $ 3,368,000  
  Accrued expenses     209,000       233,000  
  Dividends payable     -       74,000  
  Recycling fees payable     22,000       19,000  
  Line of credit     3,665,000       3,023,000  
  Current portion of long term financing obligation     95,000       90,000  
  Current portion of capital leases payable     72,000       69,000  
  Current portion of term loan     183,000       176,000  
    Total current liabilities     7,620,000       7,033,000  
                 
Long term financing obligation, less current portion, net of discount of $563,000 and $576,000, respectively     2,195,000       2,208,000  
Capital leases payable, less current portion     79,000       98,000  
Term loan, less current portion     350,000       399,000  
    Total Liabilities     10,244,000       9,738,000  
                 
Commitments and contingencies                
                 
Stockholders' equity:                
  Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 10,411 and 10,411 shares issued and outstanding, respectively     104,000       104,000  
  Series B Convertible Preferred stock, $10 par value, 500,000 shares authorized, 0 and 45,062 shares issued and outstanding, respectively     -       456,000  
  Common stock, $.0001 par value, 19,500,000 shares authorized, 12,518,333 and 12,084,673 shares issued and outstanding, respectively     1,000       1,000  
  Additional paid in capital     24,680,000       23,996,000  
  Accumulated deficit     (20,862,000 )     (20,459,000 )
    Total stockholders' equity     3,923,000       4,098,000  
    Total liabilities and stockholders' equity   $ 14,167,000     $ 13,836,000  
                 
                 
                 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 1

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 1

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 1

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 1

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 0

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

Compass Therapeutics Pursues Growth with New Public Offering

Updated Category News Views 134

Compass Therapeutics Initiates Public Offering Compass Therapeutics, Inc. (NASDAQ: CMPX), a dynamic and innovative biopharmaceutical company at the forefront of developing antibody-based therapies for cancer treatment, has announced the initiation of an underwritten public offering. This move aims to bolster its financial foundation to facilitate the advancement of its...

Continue Reading
Whirlpool Corporation Declares Substantial Quarterly Dividend

Updated Category News Views 312

Whirlpool Corporation Announces Quarterly Dividend Today, the board of directors of Whirlpool Corporation has declared a quarterly dividend of $1.75 per share on the Company's common stock. This dividend showcases the company's commitment to returning value to its shareholders. It will be payable on June 15, 2025, to stockholders of record at the close of business on May...

Continue Reading
How Tastytrade and Zerohash Transformed Account Funding

Updated Category News Views 312

Tastytrade Enables Instant Stablecoin Funding for Traders Tastytrade, the innovative online brokerage firm designed specifically for self-directed investors, has taken a significant leap forward in enhancing the trading experience. By partnering with Zerohash, they have rolled out an advanced stablecoin account funding option. This cutting-edge method allows traders...

Continue Reading
AKVA Group ASA's Strategic Buyback Program for Shares

Updated Category News Views 155

AKVA Group ASA Initiates Share Buyback Program In a recent announcement, AKVA Group ASA has taken a significant step towards enhancing its shareholder value by initiating a buyback program for up to 60,000 of its own shares. This strategic move is part of the company's plan to reinvest in its workforce through an employee share program, thereby fostering a stronger...

Continue Reading
Nvidia Stock: A Buying Opportunity Amid Market Fluctuations

Updated Category News Views 125

Nvidia Stock Sees Pre-Market Decline Shares of Nvidia Corporation (NASDAQ: NVDA) experienced a decline of 2.01% during the pre-market trading session. This drop followed the company's announcement that it had no revenue from H20 chip sales in China. This news has created some concerns among investors, although industry analysts see potential in the current situation....

Continue Reading